Please login to the form below

Not currently logged in

Adrian Hodges appointed by GSK

Adrian Hodges is joining GlaxoSmithKline as vice president of its corporate responsibility and community partnerships function

Adrian Hodges is joining GlaxoSmithKline (GSK) as vice president of the firm's corporate responsibility and community partnerships function.

Hodges joins GSK from the International Business Leaders Forum (IBLF) where he has worked since 1997, and was most recently manager director. He joins GSK in March and will report to the senior vice president for global communications, Duncan Learmonth.

Commenting on his appointment, Hodges told the IBLF: "under the leadership of CEO Andrew Witty, the company has publicly declared that it wants to build trust with stakeholders as it discharges its responsibilities."

He continued: "My role will be to build on the great work the current team have put in place and to support the company's leadership in realising ambitious business objectives in line with a focused business strategy."

Learmonth said: "Adrian brings broad experience to the company including multiple external perspectives on integrating corporate responsibility into the business. He will play a pivotal role in continuing to build GSK's relationship with society as we seek to be more open, more flexible and more transparent in how we operate our business."

16th February 2010


Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...